This was opposed to our previous results in patients with gastro-entero-pancreatic NETs, for which this relationship became nonlinear for pancreatic NETs with SUV > 25, corresponding to Ki 0.2, showing that SUV for these tumors was not an accurate measurement of SSTR expression [24, 31]. Here, PSME3 is linked to pancreatic neuroendocrine tumor.